Latest News
-

A back-to-front hidden message in the HD gene?
⏱️ 7 min read
Unzip your genes! A backwards message, hidden in the 'backup DNA' of the Huntington's disease gene… what does it me
-

Stem cells and HD: past, present and future
⏱️ 11 min read
Stem cells – who needs 'em? Scientists make brain cells from skin cells. Could this help HD?
-

Coming soon from the HD World Congress: Oz Buzz!
⏱️ 4 min read
Announcing 'Oz Buzz' – hot science news from the 2011 HD World Congress – with Ed Wild, Jeff Carroll & Charles Sabine
-

Therapeutics conference videos now online
⏱️ 1 min read
Videos of the scientific presentations from February's Huntington's disease therapeutics conference are now online
-

Cut-and-paste DNA: fixing mutations with 'genome editing'
⏱️ 7 min read
Scientists make precise changes to the DNA of a live animal. Could it work for human genetic diseases?
-

Caffeine, cannabis and caution
⏱️ 8 min read
Does caffeine accelerate Huntington's disease? Does cannabis slow it down? HDBuzz looks behind the headlines
-

Making babies: having a family, the HD way
⏱️ 17 min read
Making babies: HDBuzz's feature article – updated for 2024 – on fertility technologies that can help at-risk people to have HD-free children
-

Re-routing the huntingtin protein inside cells
⏱️ 7 min read
Canadian team decodes the tags that re-route the huntingtin protein within cells, helping explain how it becomes toxi
-

Not all in your head: digestive problems in HD
⏱️ 4 min read
Huntington's disease mice absorb less nutrition from food – which might help explain why human patients lose weight.
-

Huntexil update: EMA asks for further trial
⏱️ 2 min read
European Medicines Agency (EMA) tells NeuroSearch a European license for Huntexil in HD requires another large trial
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
Previously featured
-
EHDN 2026 Part 2: What’s the latest news for Huntington’s disease clinical trials?
-
EHDN 2026 Part 1: What’s next in the Huntington’s disease treatment pipeline?
-
Skyhawk’s drug trial takes flight in the US
-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
-
October 2026: This Month in Huntington’s Disease Research
Follow HDBuzz
Sign up to our monthly email summary by entering your email address on our mailing list page.
Suggest an article
Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.
